谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

1080Tip an Investigator-Initiated Phase I Study to Assess the Safety and Tolerability of Ex Vivo Next-Generation Neoantigen-Selected Tumor-Infiltrating Lymphocyte (TIL) Therapy in Advanced Immune Checkpoint Blockade (ICB) Resistant Solid Tumors (NEXTGENTIL-ACT)

V. Galvao,J. Palomero, I. Creus-Gonzalez,M. J. Lostes Bardaji,M. Lozano-Rabella, A. Garcia-Garijo,A. Yuste, L. Rodriguez,X. Villalobos Alberu, M. Rotxes,M. Vieito Villar,O. Saavedra Santa Gadea,G. Alonso,I. Brana,E. Munoz-Couselo, S. Querol,J. Tabernero,S. Martin-Lluesma,A. Gros,E. Garralda

Annals of Oncology（2023）

引用 0|浏览23
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要